NEW YORK, Sept. 13, 2018 /PRNewswire-PRWeb/ -- NCPDP announced today that its NCPDP eRx Validation Suite is now available
Among the enhancements in SCRIPT v2017071 are:
SCRIPT Version 2017071 also contains electronic prior authorization (ePA) transactions, as well as transactions for new prescription requests, transfers, and Risk Evaluation and Mitigation Strategy (REMS) request and response.
"NCPDP's SCRIPT Standard supports a tremendous breadth of functionality to improve administrative efficiencies and patient care," said Lee Ann Stember, President and CEO of NCPDP. "Implemented fully, SCRIPT gives providers actionable clinical data, within their existing workflows, for better informed clinical decision-making for the ultimate benefit of patients."
Access the NCPDP eRx Validation Suite at: https://ncpdp.nist.gov/ncpdp-tool/#/home?d=2017.
NCPDP has planned educational programming to help EHR and ePrescribing system vendors and other health information technology professionals plan for and maximize functionality of SCRIPT v2017071 within their product enhancements and implementations:
Register for the 2018 Educational Summit on SCRIPT by October 5, 2018, to take advantage of the Early Bird registration rate.
About NCPDP Founded in 1977, NCPDP is a not-for-profit, ANSI-accredited, Standards Development Organization with more than 1,500 members representing virtually every sector of the pharmacy services industry. Our diverse membership provides leadership and healthcare business solutions through education and standards, created using the consensus building process. NCPDP has been named in federal legislation, including HIPAA, MMA, and HITECH. NCPDP members have created standards such as the Telecommunication Standard and Batch Standard, the SCRIPT Standard for ePrescribing, the Manufacturers Rebate Standard and more to improve communication within the pharmacy industry. Our data products include dataQ®, a robust database of information on more than 80,000 pharmacies, resQ™, an industry pharmacy credentialing resource, and HCIdea®, an innovative prescriber database that provides continually updated information on more than 2.5 million prescribers. NCPDP's RxReconn® is a legislative tracking product for real-time monitoring of pharmacy-related state and national legislative and regulatory activity. For more information about NCPDP Standards, Data Services, Products, Educational Programs and Work Group meetings, go online at http://www.ncpdp.org or call 480.477.1000.
SOURCE National Council For Prescription Drug Programs, Inc.
Subscribe to our Free Newsletters!
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...View All